Latest filing published 28 May 2025 for LENSAR, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Elizabeth G. O'Farrell is a declared insider at 3 companies (board member); the most frequent names are Geron Corp, LENSAR, Inc. and PDL Biopharma, Inc. The record holds 13 filings, for trades running from 22 June 2018 to 23 May 2025.
The open-market side counts 5 purchases for €57k alongside 2 sales for €180k. The net balance comes to €123k on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 6 share grants.
A typical purchase (the median) is worth €14k. No cluster: in 5 purchases, no other insider of the company bought within 30 days.
Most recently, on 28 May 2025, the filings show a share grant in LENSAR, Inc. The latest purchase dates back some time: it was published 1,156 days ago, on 24 August 2023. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations